{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion","columns":[{"gene":"","key":"population-4a8b5e90e62d7d4332de","label":"Acute encephalopathy with biphasic seizures and late reduced diffusion","mondoId":"MONDO:0018198","onsetQualifier":null,"originColumnKey":"MONDO:0018198/ORPHA:363549","originalViews":[{"key":"MONDO:0018198/ORPHA:363549","label":"Acute encephalopathy with biphasic seizures and late reduced diffusion","scopeLabel":"ORPHA:363549","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["08a85c4d1822d588a8271053849015bc10564bbe5116b69c34c13e1a7a8ba9c5","21e1f31de2dd46eebb6b1c6ec2e6419784228444744fa614d113091339166afb","2ca81c05b5cd732c5b5179c571132ef5e9d7f8b80ca42d23ad89872294c6165b","541289f474eee4df899c1d6494796c02916a3ed2fb3aa90bb985b4ba100b64b2","5f82f2ab96514e49d1f6da00bd1cad31f8fcc601388491f365c67bf78f159297","7d760b2999a95ed9b98bc7926c9c27d9045993e21608efdd0cabb2315a48ccd3","7fa102ae06aa6dc0630da71ee08bf6f64d7100f854291319c2f3ba8c5e0138c5","90d9f914ac372618b75a92122f3688b66e6cd58000392b736ec5df593b682aaf","d25899f6820bad321b98697397959297e2b0a7b655ec48c36d89a468747bfb86","ddb365b872dd7ad03cfca1cf78c5726bb98303a45d034291e1da5ce5bbc1d948","de27f9767d5fcff032734aca6e4f6311531d5581948092d1df14e1c4a07c779f"],"recordQualifiers":{},"scopeLabel":"ORPHA:363549","sourceIds":["ORPHA:363549"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-4a8b5e90e62d7d4332de"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012705","HP:0002069","HP:0011172","HP:0007103","HP:0032308","HP:0007185","HP:0032894"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"orphanet":11}},"features":[{"hpoId":"HP:0012705","label":"Abnormal metabolic brain imaging by MRS","primary":true},{"hpoId":"HP:0002069","label":"Bilateral tonic-clonic seizure","primary":true},{"hpoId":"HP:0011172","label":"Complex febrile seizure","primary":true},{"hpoId":"HP:0007103","label":"Hypointensity of cerebral white matter on MRI","primary":true},{"hpoId":"HP:0032308","label":"Increased circulating procalcitonin concentration","primary":true},{"hpoId":"HP:0007185","label":"Loss of consciousness","primary":true},{"hpoId":"HP:0032894","label":"Seizure precipitated by febrile infection","primary":true},{"hpoId":"HP:0031691","label":"Severe viral infection","primary":false},{"hpoId":"HP:0031475","label":"Status epilepticus without prominent motor symptoms","primary":false},{"hpoId":"HP:0011665","label":"Takotsubo cardiomyopathy","primary":false},{"hpoId":"HP:0007738","label":"Uncontrolled eye movements","primary":false}],"ledeHtml":"Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a rare childhood-onset epilepsy syndrome associated with infection and characterized by a biphasic clinical course. The initial symptom is a prolonged febrile seizure on day 1 (the first phase). Afterwards, patients have variable levels of consciousness from normal to coma. Irrespective of the consciousness levels, magnetic resonance imaging (MRI) during the first 2 days shows no abnormality. During the second phase (usually days 4 - 6), patients show a cluster of seizures and deterioration of consciousness. Diffusion-weighted images (DWI) on MRI reveal the brain lesions with reduced diffusion predominantly in the subcortical white matter. After the second acute phase, consciousness levels improve with the emerging focal neurological signs. Neurological outcomes of AESD vary from normal to mild or severe sequelae including cerebral atrophy, mental retardation, paralysis and epilepsy.","mondoId":"MONDO:0018198","node":{"canonicalSlug":"acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion","comparisons":[{"documentSha256":"739a4bdce50507f878fa897a125bf10fecb2edde3ff15d3a81c5e2d0e603c35e","key":"legacy-acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion","kind":"legacy","label":"acute encephalopathy with biphasic seizures and late reduced diffusion","memberIds":["MONDO:0018198"],"mondoId":"MONDO:0018198","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion.739a4bdce50507f878fa897a125bf10fecb2edde3ff15d3a81c5e2d0e603c35e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"acute encephalopathy with biphasic seizures and late reduced diffusion","paragraphs":["Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a rare childhood-onset epilepsy syndrome associated with infection and characterized by a biphasic clinical course. The initial symptom is a prolonged febrile seizure on day 1 (the first phase). Afterwards, patients have variable levels of consciousness from normal to coma. Irrespective of the consciousness levels, magnetic resonance imaging (MRI) during the first 2 days shows no abnormality. During the second phase (usually days 4 - 6), patients show a cluster of seizures and deterioration of consciousness. Diffusion-weighted images (DWI) on MRI reveal the brain lesions with reduced diffusion predominantly in the subcortical white matter. After the second acute phase, consciousness levels improve with the emerging focal neurological signs. Neurological outcomes of AESD vary from normal to mild or severe sequelae including cerebral atrophy, mental retardation, paralysis and epilepsy."],"scope":"exact","source":"MONDO","upstream":"Orphanet:363549","url":"https://monarchinitiative.org/MONDO:0018198"},"ownColumnKeys":["population-4a8b5e90e62d7d4332de"],"publication":"published","relationships":[{"kind":"parent","label":"childhood-onset epilepsy syndrome","mondoId":"MONDO:0020072","slug":null},{"kind":"parent","label":"acute disease","mondoId":"MONDO:0020683","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/21552"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"08a85c4d1822d588a8271053849015bc10564bbe5116b69c34c13e1a7a8ba9c5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0032894","is_excluded":false,"label":"Seizure precipitated by febrile infection","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"21e1f31de2dd46eebb6b1c6ec2e6419784228444744fa614d113091339166afb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2ca81c05b5cd732c5b5179c571132ef5e9d7f8b80ca42d23ad89872294c6165b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0032308","is_excluded":false,"label":"Increased circulating procalcitonin concentration","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"541289f474eee4df899c1d6494796c02916a3ed2fb3aa90bb985b4ba100b64b2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007185","is_excluded":false,"label":"Loss of consciousness","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5f82f2ab96514e49d1f6da00bd1cad31f8fcc601388491f365c67bf78f159297","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011172","is_excluded":false,"label":"Complex febrile seizure","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7d760b2999a95ed9b98bc7926c9c27d9045993e21608efdd0cabb2315a48ccd3","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0011665","is_excluded":false,"label":"Takotsubo cardiomyopathy","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7fa102ae06aa6dc0630da71ee08bf6f64d7100f854291319c2f3ba8c5e0138c5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007738","is_excluded":false,"label":"Uncontrolled eye movements","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"90d9f914ac372618b75a92122f3688b66e6cd58000392b736ec5df593b682aaf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007103","is_excluded":false,"label":"Hypointensity of cerebral white matter on MRI","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d25899f6820bad321b98697397959297e2b0a7b655ec48c36d89a468747bfb86","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031691","is_excluded":false,"label":"Severe viral infection","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ddb365b872dd7ad03cfca1cf78c5726bb98303a45d034291e1da5ce5bbc1d948","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031475","is_excluded":false,"label":"Status epilepticus without prominent motor symptoms","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de27f9767d5fcff032734aca6e4f6311531d5581948092d1df14e1c4a07c779f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:363549","disease_name":"Acute encephalopathy with biphasic seizures and late reduced diffusion","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012705","is_excluded":false,"label":"Abnormal metabolic brain imaging by MRS","onset_id":null,"reference":"ORPHA:363549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018198\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:363549</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a rare childhood-onset epilepsy syndrome associated with infection and characterized by a biphasic clinical course. The initial symptom is a prolonged febrile seizure on day 1 (the first phase). Afterwards, patients have variable levels of consciousness from normal to coma. Irrespective of the consciousness levels, magnetic resonance imaging (MRI) during the first 2 days shows no abnormality. During the second phase (usually days 4 - 6), patients show a cluster of seizures and deterioration of consciousness. Diffusion-weighted images (DWI) on MRI reveal the brain lesions with reduced diffusion predominantly in the subcortical white matter. After the second acute phase, consciousness levels improve with the emerging focal neurological signs. Neurological outcomes of AESD vary from normal to mild or severe sequelae including cerebral atrophy, mental retardation, paralysis and epilepsy.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018198\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"acute-encephalopathy-with-biphasic-seizures-and-late-reduced-diffusion","sourceDocuments":[{"name":"MONDO: acute encephalopathy with biphasic seizures and late reduced diffusion","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018198"}],"sourceNote":"","synonyms":["acute infantile encephalopathy predominantly affecting the frontal lobes","AESD","AIEF"],"takeawayHtml":"","title":"acute encephalopathy with biphasic seizures and late reduced diffusion"},"schemaVersion":1}
